Schroder Investment Management Group
EBS icon

Schroder Investment Management Group’s Emergent Biosolutions EBS Stock Holding History

Schroder Investment Management Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,250
Closed -$54K – 1419
2021
Q4 		$54K Buy
+1,250
New +$56.5K ﹤0.01% 1323
2021
Q3 		– Sell
-1,250
Closed -$79K – 1502
2021
Q2 		$79K Hold
1,250
– – ﹤0.01% 1434
2021
Q1 		$116K Sell
1,250
-2,615
-68% -$268K ﹤0.01% 1374
2020
Q4 		$346K Sell
3,865
-45,836
-92% -$4.21M ﹤0.01% 1245
2020
Q3 		$4.98M Buy
+49,701
New +$5.36M 0.01% 724
2019
Q2 		– Sell
-9,539
Closed -$482K – 1205
2019
Q1 		$482K Sell
9,539
-147,700
-94% -$8.71M ﹤0.01% 1005
2018
Q4 		$9.32K Buy
+157,239
New +$10.1M 0.02% 570
2017
Q1 		– Sell
-8,863
Closed -$291K – 1244
2016
Q4 		$291K Sell
8,863
-414
-4% -$12.4K ﹤0.01% 1009
2016
Q3 		$293K Buy
+9,277
New +$270K ﹤0.01% 1014
2015
Q4 		– Sell
-1,250
Closed -$36K – 1192
2015
Q3 		$36K Hold
1,250
– – ﹤0.01% 1104
2015
Q2 		$40K Buy
+1,250
New +$38.8K ﹤0.01% 1128

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Schroder Investment Management Group's EBS Position: Q1 2022 in Review

Schroder Investment Management Group sold out of Emergent Biosolutions (EBS) in Q1 2022, closing a stake of 1,250 shares — an estimated $54K sold.

Schroder Investment Management Group first reported a position in EBS in Q2 2015 and held it in 11 quarters. The position peaked at $4.98M in Q3 2020. 255 funds tracked by Wall St. Rank hold EBS as of Q1 2022.

  • Schroder Investment Management Group reported no remaining Emergent Biosolutions position as of Q1 2022 after selling out during the quarter.
  • Schroder Investment Management Group sold 1,250 Emergent Biosolutions shares in Q1 2022, an estimated $54K.
  • Schroder Investment Management Group first reported a position in Emergent Biosolutions in Q2 2015 and held it in 11 quarters.
  • Schroder Investment Management Group's Emergent Biosolutions position peaked at $4.98M in Q3 2020.
  • 255 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2022.

Based on Schroder Investment Management Group's 13F filing for Q1 2022, filed 16 May 2022.